Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery.

Ganem, Fernando

Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. [electronic resource] - Interactive cardiovascular and thoracic surgery May 2011 - 778-83 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1569-9285

10.1510/icvts.2010.255257 doi


Acrylamides--blood
Aged
Biomarkers--blood
Brazil
C-Reactive Protein--metabolism
Cardiac Surgical Procedures--adverse effects
Cardiopulmonary Bypass--adverse effects
Cardiotonic Agents--therapeutic use
Chi-Square Distribution
Dobutamine--therapeutic use
Female
Hospital Mortality
Humans
Inflammation--blood
Inflammation Mediators--blood
Intensive Care Units
Interleukin-6--blood
Interleukin-8--blood
Intra-Aortic Balloon Pumping
Length of Stay
Male
Middle Aged
Natriuretic Peptide, Brain--blood
P-Selectin--blood
Postoperative Complications--blood
ROC Curve
Respiration, Artificial
Risk Assessment
Risk Factors
Time Factors
Treatment Outcome
beta-Alanine--analogs & derivatives